Rethinking Nature’s Pharmacy: AI Era and Natural Product Drug Discovery
Pharmaceuticals · 11.02.2026 · 19 (2) · 301
DOI: 10.3390/ph19020301 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 11.02.2026. Verfasst von Yipaerguli Paerhati und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, Xinjiang Medical University, Urumqi 830017, China. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tianshan Talents-Youth Science and Technology Innovation Talents Training Program of Xinjiang Autonomous Region, Natural Science Foundation for Distinguished Young Scholars of Xinjiang Autonomous Region, The "Fourteenth Five-Year Plan" Key Discipline Construction Project of Xinjiang Autonomous Region.
Abstract (Originalsprache)
Natural products (NPs) have long been a cornerstone of pharmaceutical innovation, contributing to approximately 50% of FDA-approved drugs over the past four decades. However, traditional NP drug discovery faces significant hurdles, including laborious isolation processes, biodiversity constraints, and low hit rates in high-throughput screening. These hurdles often extend the development timelines to 10–15 years with costs exceeding $2 billion per drug. Artificial intelligence (AI) emerges as a transformative force, leveraging machine learning (ML), deep learning (DL), and generative models (Gen. AI) to expedite these processes. AI facilitates virtual screening of vast chemical libraries, predicts molecular interactions with unprecedented accuracy, and designs novel NP-inspired scaffolds, potentially reducing discovery time by up to 70%. This interdisciplinary approach not only addresses unmet medical needs but also aligns with global sustainability goals, potentially increasing success rates from
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, School of Pharmacy, Xinjiang Medical University, Urumqi 830017, China.
- Xinjiang Key Laboratory of Natural Medicines Active Components and Drug Release Technology, Urumqi 830017, China.
- Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Urumqi 830017, China.
- Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education, Urumqi 830017, China.
ORCID-Profile: Dilihuma Dilimulati, Wenting Zhou
Förderung
- Tianshan Talents-Youth Science and Technology Innovation Talents Training Program of Xinjiang Autonomous Region
- Natural Science Foundation for Distinguished Young Scholars of Xinjiang Autonomous Region
- The "Fourteenth Five-Year Plan" Key Discipline Construction Project of Xinjiang Autonomous Region
- Xinjiang Key Laboratory of Natural Medicines Active Components and Drug Release Technology
- Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices
- Engineering Research Center of Xinjiang and Central Asian Medicine Resources, Ministry of Education
- The “Fourteenth Five-Year Plan” Key Discipline Construction Project of Xinjiang Autonomous Region
Zitieren
APA
Paerhati, Y., Aikebaier, A., Dilimulati, D., Baishan, A., Yusufujiang, N., Qiu, X., Wusiman, Y., & Zhou, W. (2026). Rethinking Nature’s Pharmacy: AI Era and Natural Product Drug Discovery. Pharmaceuticals, 19(2), 301. https://doi.org/10.3390/ph19020301
Vancouver
Paerhati Y, Aikebaier A, Dilimulati D, Baishan A, Yusufujiang N, Qiu X, et al. Rethinking Nature’s Pharmacy: AI Era and Natural Product Drug Discovery. Pharmaceuticals. 2026;19(2):301. doi:10.3390/ph19020301
BibTeX
@article{Paerhati2026,
author = {Paerhati, Yipaerguli and Aikebaier, Alifeiye and Dilimulati, Dilihuma and Baishan, Alhar and Yusufujiang, Nazhakaiti and Qiu, Xiaoxiao and Wusiman, Yilixiati and Zhou, Wenting},
title = {Rethinking Nature’s Pharmacy: AI Era and Natural Product Drug Discovery},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {2},
pages = {301},
doi = {10.3390/ph19020301}
}
EUVIMED